Sulaiman Injam Ibrahim, Abduljabbar Omar Ahmed, Hussein Hameed Sherwan
Department of Surgery, Hawler Medical University, College of Medicine, Erbil, IRQ.
Department of Surgery, Hawler Teaching Hospital, Erbil, IRQ.
Cureus. 2024 Dec 18;16(12):e75987. doi: 10.7759/cureus.75987. eCollection 2024 Dec.
Background and aim Trigeminal neuralgia (TN) is a chronic disorder accompanied by recurrent severe pain affecting the face. Many medical regimens are used in the treatment of trigeminal neuralgia. Neurosurgery intervention is the best treatment option, especially with the failure of medical therapy. The aim of the study was to assess the efficacy and outcomes of microvascular decompression for the management of trigeminal neuralgia in Erbil hospitals. Methods This is a prospective clinical study done to treat patients with classical or idiopathic (only patients with neurovascular compression) trigeminal neuralgia by microvascular decompression surgery. It was carried out in Hawler Hospital for cardiac and special surgery and Par Hospital in Erbil city, Kurdistan region, Iraq, from April 2023 to February 2024 on a sample of 21 patients who were diagnosed with trigeminal neuralgia. Results The preoperative mean pain severity score of patients with TN was 8.9±1.2. The means of pain severity score at early postoperative, two weeks postoperative, two months postoperative, six months postoperative, and twelve months postoperative were 2.5, 1.8, 1.3, 0.7, and 0.4, respectively. The preoperative pain severity score of patients with TN was significantly higher and showed a significant decrease postoperatively. The mean pain severity score of patients with TN was significantly reduced twelve months postoperatively. Postoperative complications were present in 14 (66.7%) patients with TN, commonly paresthesia in nine (42.9%), and hearing symptoms in five (23.8%) patients. Conclusion The microvascular decompression is an effective and safe surgical treatment of trigeminal neuralgia.
背景与目的 三叉神经痛（TN）是一种慢性疾病，伴有反复发作的严重面部疼痛。许多药物疗法用于治疗三叉神经痛。神经外科干预是最佳治疗选择，尤其是在药物治疗失败时。本研究的目的是评估在埃尔比勒医院进行微血管减压术治疗三叉神经痛的疗效和结果。方法 这是一项前瞻性临床研究，通过微血管减压手术治疗经典型或特发性（仅神经血管受压患者）三叉神经痛患者。该研究于2023年4月至2024年2月在伊拉克库尔德地区埃尔比勒市的霍勒心脏与特殊外科医院和帕尔医院进行，样本为21例被诊断为三叉神经痛的患者。结果 三叉神经痛患者术前平均疼痛严重程度评分为8.9±1.2。术后早期、术后两周、术后两个月、术后六个月和术后十二个月的疼痛严重程度评分平均值分别为2.5、1.8、1.3、0.7和0.4。三叉神经痛患者术前疼痛严重程度评分显著更高，术后显著降低。三叉神经痛患者术后十二个月平均疼痛严重程度评分显著降低。14例（66.7%）三叉神经痛患者出现术后并发症，常见的是9例（42.9%）感觉异常和5例（23.8%）听力症状。结论 微血管减压术是治疗三叉神经痛的一种有效且安全的手术方法。
